Proinflammatory and immune responses, assessed at the end of the prophylactic and therapeutic treatments, showed no significant inflammatory reaction in the brain of EB101-immunized mice, contrary to the previously reported in APP tg mouse studies [79] and Aß-vaccinated AD patients [21]. The gene discussed is APP; the disease is Alzheimer disease.